Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Altropane

From Wikipedia, the free encyclopedia
Stimulant drug
Pharmaceutical compound
Altropane
Clinical data
ATC code
  • none
Identifiers
  • Methyl (1R,2S,3S,5S)-3-(4-fluorophenyl)-8-[(E)-3-iodoprop-2-enyl]-8-azabicyclo[3.2.1]octane-2-carboxylate
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC18H21FINO2
Molar mass429.274 g·mol−1
3D model (JSmol)
  • COC(=O)[C@@H]1[C@H]2CC[C@H](N2C\C=C\I)C[C@@H]1C3=CC=C(C=C3)F
  • InChI=1S/C18H21FINO2/c1-23-18(22)17-15(12-3-5-13(19)6-4-12)11-14-7-8-16(17)21(14)10-2-9-20/h2-6,9,14-17H,7-8,10-11H2,1H3/b9-2+/t14-,15+,16+,17-/m0/s1 checkY
  • Key:GTQLIPQFXVKRKJ-UNSMHXHVSA-N checkY
  (verify)

Altropane (O-587,IACFT,2β-carbomethoxy-3β-(4-fluorophenyl)-N-((E)-3-iodo-prop-2-enyl)tropane) is aphenyltropane derivative which acts as a potentdopamine reuptake inhibitor and long-actingstimulant drug. It has mainly been used as the125Iradiolabelled form for mapping the distribution ofdopamine transporters in the brain,[1] and consequently this has led to its development as a potential diagnostic tool for early detection ofParkinson's disease.[2] It is also being investigated for potential use in the diagnosis and treatment ofattention deficit hyperactivity disorder (ADHD).[3][4]

References

[edit]
  1. ^Elmaleh DR, Fischman AJ, Shoup TM, Byon C, Hanson RN, Liang AY, et al. (July 1996). "Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites".Journal of Nuclear Medicine.37 (7):1197–202.PMID 8965198.
  2. ^Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, et al. (June 1998). "Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters".Synapse.29 (2):128–41.doi:10.1002/(SICI)1098-2396(199806)29:2<128::AID-SYN4>3.0.CO;2-9.PMID 9593103.S2CID 30543189.
  3. ^Cattabeni F (November 2002). "Altropane (Boston Life Science)".Current Opinion in Investigational Drugs.3 (11):1647–51.PMID 12476968.
  4. ^Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, et al. (November 2007)."Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane".Biological Psychiatry.62 (9):1059–61.doi:10.1016/j.biopsych.2006.12.008.PMC 2715944.PMID 17511972.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
2-Carboxymethyl Esters
(3,4-Disubstituted Phenyl)-tropanes
Arylcarboxy
Carboxyalkyl
Acyl
β,α Stereochemistry
α,β Stereochemistry
Heterocycles: 3-Substituted-isoxazol-5-yl
Heterocycles: 3-Substituted-1,2,4-oxadiazole
N-alkyl
N-replaced (S,O,C)
Irreversible
Nortropanes (N-demethylated)


Stub icon

This article related tomedical imaging is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Altropane&oldid=1190246332"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp